Why is Astec Lifescienc falling/rising?

As of 04-Jul, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 947.40, reflecting a decrease of Rs 10.6 or 1.11%. Today's price summary indicates that the stock opened with a loss of 2.89% and reached an intraday low of Rs 926, while the day's high was Rs 979.05. The stock has underperformed its sector by 1.43% today, and there has been a significant drop in investor participation, with delivery volume falling by 49.25% compared to the 5-day average. Over the past week, the stock has shown a slight increase of 0.47%, but it has underperformed the benchmark Sensex over the last year, with a return of -34.70% compared to the Sensex's 4.23% gain.
In the broader market context, the stock's recent performance reflects a consistent underperformance against the benchmark over the last three years. Despite a positive signal from rising promoter confidence, with a 4.12% increase in their stake, the company faces significant challenges, including a weak long-term fundamental strength characterized by a -212.13% CAGR growth in operating profits over the last five years. The company has reported negative results for the last four consecutive quarters, with net sales and profits falling sharply. This combination of declining financial performance and high debt levels contributes to the stock's current downward trajectory.